
Stress Tests Equipment Market
Get a free sample of this report
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.

Request Sectional Data
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Stress Tests Equipment Market was valued at USD 2.6 billion in 2023 and is anticipated to grow at a CAGR of around 6.5% between 2024 and 2032. Stress tests equipment refers to medical devices or systems designed for the purpose of conducting stress tests, which are diagnostic procedures to assess the performance and capacity of certain physiological functions under controlled or induced stress conditions. The increasing prevalence of cardiovascular diseases (CVDs) is a significant driver for the stress test equipment market. As the cardiovascular diseases represent a major global health concern and contribute to a high morbidity and mortality rate worldwide.

For instance, according to the American College of Cardiology, in 2023, global death counts due to CVD increased from 12.4 million in 1990 to 19.8 million in 2022. Thus, stress tests play a crucial role in the early detection of cardiovascular diseases, allowing healthcare professionals to identify potential issues before symptoms manifest.
Governments often launch public health campaigns to raise awareness about cardiovascular diseases and the importance of early detection. These campaigns include information about stress tests as essential diagnostic tools, contributing to increased public awareness and utilization. Further, government offer incentives or subsidies to healthcare providers to invest in advanced medical equipment, including stress test equipment. Financial support encourages healthcare facilities to upgrade their diagnostic capabilities, thereby driving market growth.
| Key Takeaway | Details |
|---|---|
| Market Size & Growth | |
| Base Year | 2023 |
| Market Size in 2023 | USD 2.6 Billion |
| Forecast Period 2024 to 2032 CAGR | 6.5% |
| Market Size in 2032 | USD 4.6 Billion |
| Key Market Trends | |
| Growth Drivers |
|
| Pitfalls & Challenges |
|
During the initial phase of the pandemic, healthcare resources were redirected towards COVID-19 care, leading to the postponement of non-urgent cardiac testing and elective procedures. This temporarily affected the demand for cardiac stress testing. Moreover, COVID-19 posed cardiovascular complications, including myocardial injury which elevated the need for cardiac testing in patients with COVID-19 to assess cardiac health and monitor potential damage. Hence, the stress testing equipment market experienced a period of decline during pandemic but later regained its momentum in the subsequent years.
Elderly and obese groups are more prone to cardiovascular diseases and related conditions, necessitating the use of stress tests for early detection, assessment, and management. As individuals age, the risk of developing conditions such as coronary artery disease and heart failure increases, the stress tests play a key role in the early detection of potential issues.

The stress tests equipment market by product type is categorized into treadmill stress test systems, ergometry equipment, cardiopulmonary exercise testing (CPET) equipment, exercise ECG systems, echocardiogram, and supplies & accessories. The treadmill stress test systems segment held a substantial revenue share in the stress tests equipment market, accounting for 18.8% in 2023.

Based on end-use, the stress tests equipment market unfolds into distinctive domains such as hospitals & clinics, diagnostic centers, ambulatory surgical centers, and other end-users. The hospitals and clinics segment dominated the market with a 50.7% revenue share in 2023 and is projected to expand at a 6.9% CAGR from 2024 to 2032.

U.S. stress tests equipment market accounted for USD 825 million revenue size in 2023 and is predicted to witness substantial market growth over the analysis timeline.
The stress tests equipment industry is consolidated, with key players including GE Healthcare, Philips Healthcare (Koninklijke Philips N.V.), Siemens Healthineers, and others dominating the market. These companies focus on ongoing product innovation, geographical expansion, and partnerships to secure substantial market shares. For instance, in October 2023, Mediport and GE HealthCare inaugurate the One-Stop Clinic for Cardiology in Antwerp, Belgium. The center aims to offer a cardiology-based diagnosis pathway including several diagnosis tests like stress test, and other diagnosis test. This strategic merger enhances GE HealthCare's diagnostic capabilities, expanding its European market portfolio.
Some of the eminent market participants operating in the stress tests equipment industry include:
Market, By Product Type
Market, By End-use
The above information is provided for the following regions and countries:
Siemens Healthineers (Siemens AG), Hill-Rom Holdings, Inc. (Baxter International Inc.), Schiller AG, Nihon Kohden, Spacelabs Healthcare (OSI Systems), Cosmed Medical, Trismed Co. Ltd , and Cardiomed Europe P.C. are some of the major stress tests equipment companies worldwide.
U.S. industry size for stress tests equipment recorded USD 825 million in 2023 and is expected to register commendable CAGR from 2024-2032 due to the high prevalence of cardiovascular diseases, prompting an increased demand for diagnostic tools in the region.
Market size for stress tests equipment was USD 3.6 billion in 2023 and is expected to reach USD 4.6 billion by 2032 due to the increasing prevalence of cardiovascular diseases (CVDs) worldwide.
The treadmill stress test systems product type segment held 18.8% share of the stress tests equipment industry in 2023 and is expected to register an appreciable CAGR from 2024-2032 owing to its versatility and widespread use for assessing cardiovascular health.


